Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01132612
What this trial is testing

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 275
Large-scale testing (Phase 3)Study completedNCT02714322
What this trial is testing

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Who this might be right for
PsoriasisArthritis, Psoriatic
Mylan Inc. 294
Not applicableStudy completedNCT00799877
What this trial is testing

Chronic Plaque Psoriasis (Ps) Registry

Who this might be right for
Chronic Plaque Psoriasis
AbbVie 6,065
Post-approval studies (Phase 4)Study completedNCT03718299
What this trial is testing

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries Limited 55
Post-approval studies (Phase 4)UnknownNCT01237262
What this trial is testing

Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors Therapy

Who this might be right for
Moderate to Severe Psoriasis.Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.
University of Padova 20
Large-scale testing (Phase 3)Study completedNCT01468233
What this trial is testing

Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa (HS)
AbbVie (prior sponsor, Abbott) 326
Testing effectiveness (Phase 2)Study completedNCT04080206
What this trial is testing

A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 55
Not applicableStudy completedNCT01401452
What this trial is testing

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 246
Not applicableStudy completedNCT05787236
What this trial is testing

Moderate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world Setting

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 79
Large-scale testing (Phase 3)Ended earlyNCT02527421
What this trial is testing

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Primus Pharmaceuticals 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090330
What this trial is testing

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT03384745
What this trial is testing

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Bond Avillion 2 Development LP 313
Not applicableStudy completedNCT01126619
What this trial is testing

Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Abbott 103
Testing effectiveness (Phase 2)Study completedNCT01988103
What this trial is testing

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Who this might be right for
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Amgen 254
Post-approval studies (Phase 4)Study completedNCT03988439
What this trial is testing

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 16
Large-scale testing (Phase 3)Study completedNCT01276639
What this trial is testing

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 901
Testing effectiveness (Phase 2)Study completedNCT02413229
What this trial is testing

Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Large-scale testing (Phase 3)Study completedNCT03210259
What this trial is testing

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 259
Large-scale testing (Phase 3)Study completedNCT00307437
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 1,230
Not applicableLooking for participantsNCT03392337
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 30
Next Page